Literature DB >> 29676453

Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink.

Parisa Karimi1, Brenda M Birmann2, Lesley A Anderson3, Charlene M McShane3, Shahinaz M Gadalla4, Joshua N Sampson5, Sam M Mbulaiteye1.   

Abstract

Burkitt lymphoma (BL) occurs as three subtypes: endemic BL, immunosuppression-related BL and sporadic BL. Descriptive studies of BL age-specific incidence patterns have suggested multimodal peaks near 10, 40 and 70 years of age, but the risk factors for BL at different ages are unknown. We investigated risk factors for BL in the United Kingdom among 156 BL cases and 608 matched BL-free controls identified in the Clinical Practice Research Datalink (CPRD) between 1992 and 2016. Associations with pre-diagnostic body mass index, cigarette smoking, alcohol consumption, hepatitis, Epstein-Barr virus (EBV), human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS), malaria, allergic and autoimmune conditions, and prednisone use were evaluated. Overall, we identified inverse associations between smoking and BL risk, and positive associations between prior EBV infection, HIV/AIDS and prescription or use of prednisone with BL risk. In age-group stratified analyses, BL was associated with malaria exposure (vs. no exposure, odds ratio [OR] 8·00, 95% confidence interval [CI] 1·46-43·7) among those aged 20-59 years old and with hepatitis infection (vs. no infection, OR 3·41, 95% CI 1·01-11·5) among those aged 60+ years old. The effects of EBV, malaria, HIV/AIDS, prednisone and hepatitis on BL remained significant in mutually-adjusted age-group-specific analyses. No risk factors were associated with childhood BL. We report novel associations for BL in non-endemic settings.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Burkitt lymphoma; Epstein-Barr virus; Falciparum malaria; prednisone; smoking

Mesh:

Year:  2018        PMID: 29676453      PMCID: PMC5980720          DOI: 10.1111/bjh.15229

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  37 in total

1.  Epidemiological evidence of the nature of Hodgkin's disease.

Authors:  B MACMAHON
Journal:  Cancer       Date:  1957 Sep-Oct       Impact factor: 6.860

Review 2.  Endemic Burkitt's lymphoma: a polymicrobial disease?

Authors:  Rosemary Rochford; Martin J Cannon; Ann M Moormann
Journal:  Nat Rev Microbiol       Date:  2005-02       Impact factor: 60.633

Review 3.  Part I: Cancer in Indigenous Africans--burden, distribution, and trends.

Authors:  D Max Parkin; Freddy Sitas; Mike Chirenje; Lara Stein; Raymond Abratt; Henry Wabinga
Journal:  Lancet Oncol       Date:  2008-07       Impact factor: 41.316

Review 4.  XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus.

Authors:  Feng-Yen Li; Benjamin Chaigne-Delalande; Helen Su; Gulbu Uzel; Helen Matthews; Michael J Lenardo
Journal:  Blood       Date:  2014-02-18       Impact factor: 22.113

5.  Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa.

Authors:  Sam M Mbulaiteye; William F Anderson; Jacques Ferlay; Kishor Bhatia; Cindy Chang; Philip S Rosenberg; Susan S Devesa; Donald M Parkin
Journal:  Am J Hematol       Date:  2012-04-10       Impact factor: 10.047

6.  Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited.

Authors:  Martin D Ogwang; Kishor Bhatia; Robert J Biggar; Sam M Mbulaiteye
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

7.  Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Sam M Mbulaiteye; Lindsay M Morton; Joshua N Sampson; Ellen T Chang; Laura Costas; Silvia de Sanjosé; Tracy Lightfoot; Jennifer Kelly; Jonathan W Friedberg; Wendy Cozen; Rafael Marcos-Gragera; Susan L Slager; Brenda M Birmann; Dennis D Weisenburger
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

8.  Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.

Authors:  Lucy M Carpenter; Robert Newton; Delphine Casabonne; John Ziegler; Sam Mbulaiteye; Edward Mbidde; Henry Wabinga; Harold Jaffe; Valerie Beral
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

9.  Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

Authors:  Henrik Hjalgrim; Johan Askling; Klaus Rostgaard; Stephen Hamilton-Dutoit; Morten Frisch; Jin-Song Zhang; Mette Madsen; Nils Rosdahl; Helle Bossen Konradsen; Hans H Storm; Mads Melbye
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

10.  Evaluating the Causal Link Between Malaria Infection and Endemic Burkitt Lymphoma in Northern Uganda: A Mendelian Randomization Study.

Authors:  Ismail D Legason; Ruth M Pfeiffer; Krizia-Ivana Udquim; Andrew W Bergen; Mateus H Gouveia; Samuel Kirimunda; Isaac Otim; Eric Karlins; Patrick Kerchan; Hadijah Nabalende; Ariunaa Bayanjargal; Benjamin Emmanuel; Paul Kagwa; Ambrose O Talisuna; Kishor Bhatia; Meredith Yeager; Robert J Biggar; Leona W Ayers; Steven J Reynolds; James J Goedert; Martin D Ogwang; Joseph F Fraumeni; Ludmila Prokunina-Olsson; Sam M Mbulaiteye
Journal:  EBioMedicine       Date:  2017-10-03       Impact factor: 8.143

View more
  4 in total

1.  Epidemiology of adult and pediatric Burkitt lymphoma in Canada: sequelae of the HIV epidemic.

Authors:  S F Roy; F M Ghazawi; M Le; F Lagacé; C F Roy; E Rahme; E Savin; A Zubarev; D Sasseville; G Popradi; I V Litvinov
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

2.  Epstein-Barr virus and Burkitt's lymphoma. Associations in Iraqi Kurdistan and twenty-two countries assessed in the International Incidence of Childhood Cancer.

Authors:  Dana N Muhealdeen; Alan Shwan; Rafil T Yaqo; Hemin A Hassan; Bryar O Muhammed; Rawa M Ali; Michael D Hughson
Journal:  Infect Agent Cancer       Date:  2022-07-27       Impact factor: 3.698

3.  Malaria and risk of lymphoid neoplasms and other cancer: a nationwide population-based cohort study.

Authors:  Katja Wyss; Fredrik Granath; Andreas Wångdahl; Therese Djärv; Michael Fored; Pontus Naucler; Anna Färnert
Journal:  BMC Med       Date:  2020-10-30       Impact factor: 8.775

Review 4.  Quercetin as a Novel Therapeutic Approach for Lymphoma.

Authors:  Saiedeh Razi Soofiyani; Kamran Hosseini; Haleh Forouhandeh; Tohid Ghasemnejad; Vahideh Tarhriz; Parina Asgharian; Željko Reiner; Javad Sharifi-Rad; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-08-02       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.